tolazamide |
1156-19-0 |
Tolinase |
Norglycin |
Tolanase |
Diabewas |
Tolazolamide |
Tolazamida |
Tolazamidum |
1-(Hexahydro-1-azepinyl)-3-p-tolylsulfonylurea |
N-(p-Toluenesulfonyl)-N-hexamethyleniminourea |
U-17835 |
4-(p-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide |
NCI-C03327 |
1-(Hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea |
1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea |
U 17835 |
CCRIS 591 |
NSC-70762 |
UNII-9LT1BRO48Q |
Urea, 1-(hexahydroazepin-1-yl)-3-p-tolylsulfonyl- |
EINECS 214-588-3 |
Urea, 1-(hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)- |
BRN 1323565 |
Benzenesulfonamide, N-(hexahydro-1H-azepin-1-yl)aminocarbonyl-4-methyl- |
9LT1BRO48Q |
MLS000028534 |
CHEBI:9613 |
N-(azepan-1-ylamino)carbonyl-4-methylbenzenesulfonamide |
N-(((Hexahydro-1H-azepin-1-yl)-amino)carbonyl)-4-methylbenzenesulfonamide |
NSC70762 |
N-(azepan-1-ylcarbamoyl)-4-methylbenzenesulfonamide |
Benzenesulfonamide, N-(((hexahydro-1H-azepin-1-yl)amino)carbonyl)-4-methyl- |
1-(Hexahydro-1H-azepin-1-yl)-3-(p-toluenesulfonyl)urea |
NCGC00016009-10 |
SMR000058290 |
CAS-1156-19-0 |
DSSTox_CID_1358 |
DSSTox_RID_76105 |
DSSTox_GSID_21358 |
Tolazamidum INN-Latin |
Tolazamida INN-Spanish |
1-(((((4-Methylphenyl)sulfonyl)amino)carbonyl)amino)azepane |
Tolinase (TN) |
HSDB 3192 |
SR-01000003105 |
NSC 70762 |
1-(Azepan-1-ylamino)carbonyl-4-methylbenzenesulfonamide |
1-({(4-methylphenyl)sulfonylamino}carbonyl)aminoazepane |
Ronase |
(azaperhydroepinylamino)-N-(4-methylphenyl)sulfonylcarboxamide |
AI3-50826 |
N-{(hexahydro-1H-azepin-1-yl)-aminocarbonyl}-4-methylbenzenesulfonamide |
Prestwick_865 |
Tolazamide USAN:USP:INN:BAN:JAN |
Spectrum_001269 |
Opera_ID_1740 |
Prestwick0_000554 |
Prestwick1_000554 |
Prestwick2_000554 |
Prestwick3_000554 |
Spectrum2_001449 |
Spectrum3_001473 |
Spectrum4_000240 |
Spectrum5_001204 |
Lopac-T-2408 |
CHEMBL817 |
Benzenesulfonamide, N-(((hexahydro-1H-azepin-1-yl)-amino)carbonyl)-4-methyl- |
T 2408 |
3-azepan-1-yl-1-(4-methylphenyl)sulfonyl-urea |
NCIOpen2_008361 |
CBiol_001918 |
Lopac0_001195 |
Oprea1_061180 |
SCHEMBL34417 |
BSPBio_000627 |
BSPBio_001505 |
BSPBio_003025 |
KBioGR_000225 |
KBioGR_000939 |
KBioSS_000225 |
KBioSS_001749 |
Tolazamide (JAN/USP/INN) |
1-(azepan-1-yl)-3-(4-methylbenzenesulfonyl)urea |
5-20-04-00062 (Beilstein Handbook Reference) |
MLS001076161 |
DivK1c_000212 |
SPECTRUM1501201 |
SPBio_001317 |
SPBio_002548 |
BPBio1_000691 |
GTPL6847 |
WLN: T7NTJ AMVMSWR D1 |
DTXSID3021358 |
BCBcMAP01_000061 |
HMS500K14 |
KBio1_000212 |
KBio2_000225 |
KBio2_001749 |
KBio2_002793 |
KBio2_004317 |
KBio2_005361 |
KBio2_006885 |
KBio3_000449 |
KBio3_000450 |
KBio3_002525 |
ZINC57512 |
NINDS_000212 |
Bio1_000204 |
Bio1_000693 |
Bio1_001182 |
Bio2_000225 |
Bio2_000705 |
HMS1361L07 |
HMS1569P09 |
HMS1791L07 |
HMS1921P19 |
HMS1989L07 |
HMS2089L10 |
HMS2092L09 |
HMS2096P09 |
HMS2232L21 |
HMS3259O18 |
HMS3263P11 |
HMS3369L04 |
HMS3402L07 |
HMS3713P09 |
Pharmakon1600-01501201 |
BCP23550 |
HY-B0920 |
Tox21_110281 |
Tox21_201507 |
Tox21_300416 |
Tox21_501195 |
2761AH |
CCG-39178 |
MFCD00083504 |
NSC758149 |
SBB058190 |
AKOS015913823 |
N-(Hexahydro-1H-azepin-1-yl)aminocarbonyl-4-methylbenzenesulfonamide |
Tox21_110281_1 |
ACN-053046 |
DB00839 |
KS-1438 |
LP01195 |
MCULE-9265102499 |
NC00590 |
NSC-758149 |
SDCCGSBI-0051162.P004 |
Benzenesulfonamide, {N-(hexahydro-1H-azepin-1-yl)aminocarbonyl-4-methyl-} |
IDI1_000212 |
IDI1_033975 |
NCGC00016009-01 |
NCGC00016009-02 |
NCGC00016009-03 |
NCGC00016009-04 |
NCGC00016009-05 |
NCGC00016009-06 |
NCGC00016009-07 |
NCGC00016009-08 |
NCGC00016009-09 |
NCGC00016009-11 |
NCGC00016009-12 |
NCGC00016009-13 |
NCGC00016009-14 |
NCGC00016009-15 |
NCGC00016009-16 |
NCGC00016009-17 |
NCGC00016009-19 |
NCGC00016009-24 |
NCGC00023701-03 |
NCGC00023701-04 |
NCGC00023701-05 |
NCGC00023701-06 |
NCGC00023701-07 |
NCGC00023701-08 |
NCGC00023701-09 |
NCGC00023701-10 |
NCGC00254501-01 |
NCGC00259058-01 |
NCGC00261880-01 |
1-(azepan-1-yl)-3-(p-tolylsulfonyl)urea |
SBI-0051162.P003 |
AB00052247 |
EU-0101195 |
FT-0675268 |
ST51015133 |
SW196991-3 |
C71499 |
D00379 |
AB00052247-15 |
AB00052247_16 |
AB00052247_17 |
A921617 |
1-(azepan-1-yl)-3-(4-methylbenzene)sulfonylurea |
Q7814101 |
SR-01000003105-2 |
SR-01000003105-4 |
SR-01000003105-5 |
SR-01000003105-8 |
W-109110 |
BRD-K32164935-001-06-8 |
BRD-K32164935-001-17-5 |
BRD-K32164935-001-28-2 |
F2173-1137 |
1-(4-Methylphenylsulfonyl)-3-(hexahydro-1H-azepin-1-yl)urea |
1-(((4-Methylphenyl)sulfonylamino)carbonyl)aminoazepane # |
Tolazamide, United States Pharmacopeia (USP) Reference Standard |
Benzenesulfonamide, N-(hexahydro-1-azepinyl)aminocarbonyl-4-methyl- |